SEPTANEST 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 1.7mL solution for injection Australië - Engels - Department of Health (Therapeutic Goods Administration)

septanest 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 1.7ml solution for injection

specialites septodont pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); articaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; sodium hydroxide; water for injections - for local or regional anaesthesia for both simple and complex dental procedures in adult, adolescents and children 4 years of age and older. septanest 1:100,000 is indicated only for dental procedures.

LASIX flurosemide (frusemide) 40 mg tablet bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

lasix flurosemide (frusemide) 40 mg tablet bottle

sanofi-aventis australia pty ltd - furosemide, quantity: 40 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; sunset yellow fcf; purified talc; quinoline yellow aluminium lake; lactose monohydrate; maize starch; magnesium stearate - oedema: lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical. hypertension. oral lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately control

BERIPLEX P/N human prothrombin complex 1000 IU powder for injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

beriplex p/n human prothrombin complex 1000 iu powder for injection vial

csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

BERIPLEX P/N human prothrombin complex 500 IU powder for injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

beriplex p/n human prothrombin complex 500 iu powder for injection vial

csl behring australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

BELKYRA deoxycholic acid 10 mg/mL injection glass vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

belkyra deoxycholic acid 10 mg/ml injection glass vial

abbvie pty ltd - deoxycholic acid, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dibasic sodium phosphate heptahydrate; hydrochloric acid - belkyra (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults

DELTAZINE 1:200,000 articaine HCl 4% with adrenaline 1:200,000, solution for injection 2.2 mL cartridge Australië - Engels - Department of Health (Therapeutic Goods Administration)

deltazine 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 2.2 ml cartridge

specialites septodont pty ltd - articaine hydrochloride, quantity: 88 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.02 mg (equivalent: adrenaline (epinephrine), qty 0.011 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - deltazine 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. deltazine 1:200,000 is indicated only for dental procedures

DELTAZINE 1:200,000 articaine HCl 4% with adrenaline 1:200,000, solution for injection 1.7 ml cartridge Australië - Engels - Department of Health (Therapeutic Goods Administration)

deltazine 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 1.7 ml cartridge

specialites septodont pty ltd - articaine hydrochloride, quantity: 68 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.0155 mg (equivalent: adrenaline (epinephrine), qty 0.0085 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - deltazine 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. deltazine 1:200,000 is indicated only for dental procedures

FIRMAGON degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite pack of 80mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 4.2 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

firmagon degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe

ferring pharmaceuticals pty ltd - water for injections, quantity: 3 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

DELTAZINE 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2mL solution for injection Australië - Engels - Department of Health (Therapeutic Goods Administration)

deltazine 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2ml solution for injection

specialites septodont pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 10 microgram/ml; articaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium metabisulfite; sodium chloride - for local or regional anaesthesia for both simple and complex dental procedures in adult, adolescents and children 4 years of age and older. deltazine 1:100,000 is indicated only for dental procedures.